Company overview
Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as the Genesis RMN, which enable physicians to complete interventional procedures by providing image-guided delivery of catheters and guidewires through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN, which is designed to enhance the accessibility of RMN by eliminating the lengthy construction cycle necessary to install prior generation RMN systems. It also offers Odyssey, a real-time information solution to manage, control, record, and share procedures across networks; and x-ray systems. In addition, the company offers disposables and other accessories, including QuikCAS, an automated catheter advancement single-use disposable device; iCONNECT; V-CAS; and MAGiC catheter for cardiac ablation procedures. Further, it provides Vdrive, a system that offers navigation and stability for the diagnostic and therapeutic devices designed to improve interventional procedures; and V-Loop, V-Sono, and V-CAS disposable components. It markets its products through direct sales force, distributors, and sales agents. Stereotaxis, Inc. was incorporated in 1990 and is based in Saint Louis, Missouri.
Daily valuation snapshot
These values come from the daily market snapshot dated 2026-10-08. TTM means trailing twelve months. Use the market date when comparing STXS with another company.
| Daily close (USD) | $1.11 |
| Market capitalization (USD) | $111,224,417.58 |
| Price / earnings (TTM) | Not reported |
| Price / book | 6.36 |
No matching rows. Clear the filter to see all records.
Read STXS's valuation metrics
Company size
Stereotaxis, Inc. Common Stock's recorded market capitalization is $111,224,417.58. It measures the market value of the company's equity, rather than its revenue or cash balance.
Price relative to earnings
P/E compares share price with trailing annual earnings per share. For a company with losses, inspect the earnings figures directly rather than treating a negative multiple as a cheap valuation.
Price relative to book equity
STXS's recorded price-to-book ratio is 6.36. That compares its market equity value with recorded book equity. Examine its business and balance sheet to understand why those values differ.
Research Stereotaxis, Inc. Common Stock with Aurora
Use the snapshot above to ask a specific question about STXS. Ask for the report period and the figures behind the explanation, then compare the answer with the company's business description.
Continue the research
Follow STXS's ownership disclosures to see who filed a transaction or position and when it became public. To turn a research idea into a strategy, define an entry rule and test its dated observations.